Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

First launch for lipid-lowering statin

Feb. 19, 1997

Japanese introduction for new formulation of epoetin alfa

Feb. 18, 1997

Human Genome Sciences describes MCP-4 polypeptide

Feb. 14, 1997

EPO activators/agonists described by J&J and Affymax

Feb. 14, 1997

Harvard Scientific's impotence drug advances in European trials

Feb. 13, 1997

U.S. patent covers DLK gene

Feb. 13, 1997

PPL reports progress in transgenic cow program

Feb. 13, 1997

AGE inhibitors reported by Kissei

Feb. 13, 1997

NexMed licenses alprostadil cream

Feb. 12, 1997

Menorest approved in 29 markets

Feb. 12, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...